

Is Ethosuximide in shortage in 2026? Get the latest update on Ethosuximide (Zarontin) availability, pricing, and what patients can do right now.
If you've had trouble picking up your Ethosuximide prescription lately, you're probably wondering: is there an official shortage? The short answer is that Ethosuximide is not currently listed on the FDA or ASHP drug shortage databases as of early 2026. But that doesn't mean it's easy to find.
Ethosuximide (brand name: Zarontin) is a niche anticonvulsant used primarily for absence seizures. Because it serves a relatively small patient population and only a few companies manufacture it, availability can be inconsistent—even without a formal shortage declaration. Many patients report difficulty finding it at their local pharmacies.
Even without an official shortage, several factors can make Ethosuximide difficult to locate:
Most retail pharmacies stock medications based on how frequently they're dispensed. Ethosuximide is prescribed far less often than common medications like blood pressure pills or diabetes drugs. As a result, many pharmacies—especially large chains—simply don't keep it on their shelves.
Only a small number of pharmaceutical companies produce generic Ethosuximide. Pfizer manufactures the brand-name Zarontin oral solution. With so few producers, any disruption in manufacturing can create ripple effects across the supply chain.
When supply is limited, wholesalers may allocate stock to their highest-volume pharmacy customers first. This can leave smaller or independent pharmacies—which may actually be more willing to order Ethosuximide—waiting for their shipments.
Even if Ethosuximide is technically available nationally, it may be out of stock in your specific region. Supply chain logistics mean that some areas experience temporary gaps more than others.
Cost is another challenge for Ethosuximide patients. Here's what you can expect:
For a complete guide to saving money, read our post on how to save money on Ethosuximide in 2026.
While no new medications have been specifically approved for absence seizures in recent years, the existing treatment options remain effective:
If you're considering a switch, our post on alternatives to Ethosuximide covers the pros and cons of each option in detail.
Here are your best strategies for locating Ethosuximide right now:
Medfinder helps you search for pharmacies that have Ethosuximide in stock near your location. It's the fastest way to check availability without making dozens of phone calls.
Independent pharmacies are often more willing to special-order niche medications. They may also have access to different wholesalers than chain pharmacies.
Mail-order pharmacies operate from large central warehouses and may have better access to less common medications. Check with your insurance plan's mail-order option.
Ethosuximide is available as 250 mg capsules and a 250 mg/5 mL oral solution. If one form is out of stock, the other may be available. Talk to your prescriber about switching formulations if needed.
Request refills 1 to 2 weeks early so your pharmacy has time to order Ethosuximide if they don't have it in stock.
For more detailed tips, see our guide on how to find Ethosuximide in stock near you.
While there is no official Ethosuximide shortage in 2026, the reality on the ground is that many patients struggle to find it. The combination of low demand, limited manufacturers, and inconsistent pharmacy stocking creates a situation where this important seizure medication can feel scarce.
The best thing you can do is plan ahead, use tools like Medfinder, and keep your neurologist informed. If you're having ongoing difficulty, ask about alternatives or reach out to Pfizer's patient assistance program (Pfizer RxPathways: 1-844-989-4366) for additional support.
Stay informed about your medication. For a complete overview, read What is Ethosuximide?
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.